CNBC's "Fast Money" Semis Slide, Oil Climbs, Nike Results on Deck… And The Latest Use Case For GLP-1’s 3/30/26
9 snips
Mar 30, 2026 Jared Holes, a Mizuho healthcare specialist who covers biotech and pharma, discusses Eli Lilly’s push into GLP-1s and a surprising new use case in addiction trials. He also breaks down recent biotech deals and what these moves mean for the broader pharmaceutical landscape. Short, sharp takes on catalysts and sector implications.
AI Snips
Chapters
Transcript
Episode notes
Memory Stocks' Intraday Collapse Signals Leadership Shift
- Semiconductor memory names led a sharp intraday reversal, signaling a broader leadership shift away from semiconductors.
- Micron, Seagate and Western Digital opened strong then finished >9% off highs, with Micron down ~32% since earnings, showing cyclical risk in memory.
Bond Rally With Oil Rise Indicates Growth Fear
- Bonds rallied the same day oil rose, implying a flight to perceived quality amid growth concerns rather than simple inflation hedging.
- Katie Stockton noted bond-to-equity ratios moving above 200-day averages, unlike 2022, suggesting a different bear-cycle dynamic.
Dip A Toe Back Into Large Cap Tech
- Consider beginning to deploy capital on large-cap tech and select names trading at pandemic trough valuations.
- Julian Emanuel recommends dipping a toe into MAG7 stocks because they have visible earnings and attractive prices if oil stabilizes.